0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Innovative Drug CRO (Contract Research Organisation) Market Research Report 2025
Published Date: 2025-05-06
|
Report Code: QYRE-Auto-30B16036
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Innovative Drug CRO Contract Research Organisation Market Research Report 2023
BUY CHAPTERS

Global Innovative Drug CRO (Contract Research Organisation) Market Research Report 2025

Code: QYRE-Auto-30B16036
Report
2025-05-06
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Innovative Drug CRO (Contract Research Organisation) Market

The global market for Innovative Drug CRO (Contract Research Organisation) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Innovative Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Innovative Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Innovative Drug CRO (Contract Research Organisation) in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Innovative Drug CRO (Contract Research Organisation) include Charles River, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv, ChemPartner, JOINN Lab, EVOTEC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Innovative Drug CRO (Contract Research Organisation), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Innovative Drug CRO (Contract Research Organisation).
The Innovative Drug CRO (Contract Research Organisation) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Innovative Drug CRO (Contract Research Organisation) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Innovative Drug CRO (Contract Research Organisation) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Innovative Drug CRO (Contract Research Organisation) Market Report

Report Metric Details
Report Name Innovative Drug CRO (Contract Research Organisation) Market
Segment by Type
Segment by Application
  • Pharmaceutical Companies
  • MAH Customer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv, ChemPartner, JOINN Lab, EVOTEC, Medicilon, Crown Bioscience, Champion Oncology, IQVIA, Parexel, Syneos Health, MedPace, Wuxi AppTec, SUNNOVO, Pharmaron Beijing, Hangzhou Tigermed Consulting
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Innovative Drug CRO (Contract Research Organisation) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Innovative Drug CRO (Contract Research Organisation) Market report?

Ans: The main players in the Innovative Drug CRO (Contract Research Organisation) Market are Charles River, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv, ChemPartner, JOINN Lab, EVOTEC, Medicilon, Crown Bioscience, Champion Oncology, IQVIA, Parexel, Syneos Health, MedPace, Wuxi AppTec, SUNNOVO, Pharmaron Beijing, Hangzhou Tigermed Consulting

What are the Application segmentation covered in the Innovative Drug CRO (Contract Research Organisation) Market report?

Ans: The Applications covered in the Innovative Drug CRO (Contract Research Organisation) Market report are Pharmaceutical Companies, MAH Customer, Others

What are the Type segmentation covered in the Innovative Drug CRO (Contract Research Organisation) Market report?

Ans: The Types covered in the Innovative Drug CRO (Contract Research Organisation) Market report are Clinical CRO, Preclinical CRO

Recommended Reports

CRO Services Market

Clinical CRO Markets

Innovative & Biopharma

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Clinical CRO
1.2.3 Preclinical CRO
1.3 Market by Application
1.3.1 Global Innovative Drug CRO (Contract Research Organisation) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 MAH Customer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Innovative Drug CRO (Contract Research Organisation) Market Perspective (2020-2031)
2.2 Global Innovative Drug CRO (Contract Research Organisation) Growth Trends by Region
2.2.1 Global Innovative Drug CRO (Contract Research Organisation) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Innovative Drug CRO (Contract Research Organisation) Historic Market Size by Region (2020-2025)
2.2.3 Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031)
2.3 Innovative Drug CRO (Contract Research Organisation) Market Dynamics
2.3.1 Innovative Drug CRO (Contract Research Organisation) Industry Trends
2.3.2 Innovative Drug CRO (Contract Research Organisation) Market Drivers
2.3.3 Innovative Drug CRO (Contract Research Organisation) Market Challenges
2.3.4 Innovative Drug CRO (Contract Research Organisation) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Innovative Drug CRO (Contract Research Organisation) Players by Revenue
3.1.1 Global Top Innovative Drug CRO (Contract Research Organisation) Players by Revenue (2020-2025)
3.1.2 Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Players (2020-2025)
3.2 Global Innovative Drug CRO (Contract Research Organisation) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Innovative Drug CRO (Contract Research Organisation) Revenue
3.4 Global Innovative Drug CRO (Contract Research Organisation) Market Concentration Ratio
3.4.1 Global Innovative Drug CRO (Contract Research Organisation) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Innovative Drug CRO (Contract Research Organisation) Revenue in 2024
3.5 Global Key Players of Innovative Drug CRO (Contract Research Organisation) Head office and Area Served
3.6 Global Key Players of Innovative Drug CRO (Contract Research Organisation), Product and Application
3.7 Global Key Players of Innovative Drug CRO (Contract Research Organisation), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Innovative Drug CRO (Contract Research Organisation) Breakdown Data by Type
4.1 Global Innovative Drug CRO (Contract Research Organisation) Historic Market Size by Type (2020-2025)
4.2 Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031)
5 Innovative Drug CRO (Contract Research Organisation) Breakdown Data by Application
5.1 Global Innovative Drug CRO (Contract Research Organisation) Historic Market Size by Application (2020-2025)
5.2 Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
6.2 North America Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
6.4 North America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
7.2 Europe Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
7.4 Europe Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
8.2 Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025)
8.4 Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
9.2 Latin America Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
9.4 Latin America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size (2020-2031)
10.2 Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
10.4 Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Innovative Drug CRO (Contract Research Organisation) Introduction
11.1.4 Charles River Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Innovative Drug CRO (Contract Research Organisation) Introduction
11.2.4 Labcorp Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.2.5 Labcorp Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Innovative Drug CRO (Contract Research Organisation) Introduction
11.3.4 Eurofins Scientific Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.3.5 Eurofins Scientific Recent Development
11.4 PPD
11.4.1 PPD Company Details
11.4.2 PPD Business Overview
11.4.3 PPD Innovative Drug CRO (Contract Research Organisation) Introduction
11.4.4 PPD Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.4.5 PPD Recent Development
11.5 ICON Plc
11.5.1 ICON Plc Company Details
11.5.2 ICON Plc Business Overview
11.5.3 ICON Plc Innovative Drug CRO (Contract Research Organisation) Introduction
11.5.4 ICON Plc Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.5.5 ICON Plc Recent Development
11.6 Pharmaron
11.6.1 Pharmaron Company Details
11.6.2 Pharmaron Business Overview
11.6.3 Pharmaron Innovative Drug CRO (Contract Research Organisation) Introduction
11.6.4 Pharmaron Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.6.5 Pharmaron Recent Development
11.7 Inotiv
11.7.1 Inotiv Company Details
11.7.2 Inotiv Business Overview
11.7.3 Inotiv Innovative Drug CRO (Contract Research Organisation) Introduction
11.7.4 Inotiv Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.7.5 Inotiv Recent Development
11.8 ChemPartner
11.8.1 ChemPartner Company Details
11.8.2 ChemPartner Business Overview
11.8.3 ChemPartner Innovative Drug CRO (Contract Research Organisation) Introduction
11.8.4 ChemPartner Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.8.5 ChemPartner Recent Development
11.9 JOINN Lab
11.9.1 JOINN Lab Company Details
11.9.2 JOINN Lab Business Overview
11.9.3 JOINN Lab Innovative Drug CRO (Contract Research Organisation) Introduction
11.9.4 JOINN Lab Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.9.5 JOINN Lab Recent Development
11.10 EVOTEC
11.10.1 EVOTEC Company Details
11.10.2 EVOTEC Business Overview
11.10.3 EVOTEC Innovative Drug CRO (Contract Research Organisation) Introduction
11.10.4 EVOTEC Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.10.5 EVOTEC Recent Development
11.11 Medicilon
11.11.1 Medicilon Company Details
11.11.2 Medicilon Business Overview
11.11.3 Medicilon Innovative Drug CRO (Contract Research Organisation) Introduction
11.11.4 Medicilon Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.11.5 Medicilon Recent Development
11.12 Crown Bioscience
11.12.1 Crown Bioscience Company Details
11.12.2 Crown Bioscience Business Overview
11.12.3 Crown Bioscience Innovative Drug CRO (Contract Research Organisation) Introduction
11.12.4 Crown Bioscience Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.12.5 Crown Bioscience Recent Development
11.13 Champion Oncology
11.13.1 Champion Oncology Company Details
11.13.2 Champion Oncology Business Overview
11.13.3 Champion Oncology Innovative Drug CRO (Contract Research Organisation) Introduction
11.13.4 Champion Oncology Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.13.5 Champion Oncology Recent Development
11.14 IQVIA
11.14.1 IQVIA Company Details
11.14.2 IQVIA Business Overview
11.14.3 IQVIA Innovative Drug CRO (Contract Research Organisation) Introduction
11.14.4 IQVIA Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.14.5 IQVIA Recent Development
11.15 Parexel
11.15.1 Parexel Company Details
11.15.2 Parexel Business Overview
11.15.3 Parexel Innovative Drug CRO (Contract Research Organisation) Introduction
11.15.4 Parexel Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.15.5 Parexel Recent Development
11.16 Syneos Health
11.16.1 Syneos Health Company Details
11.16.2 Syneos Health Business Overview
11.16.3 Syneos Health Innovative Drug CRO (Contract Research Organisation) Introduction
11.16.4 Syneos Health Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.16.5 Syneos Health Recent Development
11.17 MedPace
11.17.1 MedPace Company Details
11.17.2 MedPace Business Overview
11.17.3 MedPace Innovative Drug CRO (Contract Research Organisation) Introduction
11.17.4 MedPace Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.17.5 MedPace Recent Development
11.18 Wuxi AppTec
11.18.1 Wuxi AppTec Company Details
11.18.2 Wuxi AppTec Business Overview
11.18.3 Wuxi AppTec Innovative Drug CRO (Contract Research Organisation) Introduction
11.18.4 Wuxi AppTec Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.18.5 Wuxi AppTec Recent Development
11.19 SUNNOVO
11.19.1 SUNNOVO Company Details
11.19.2 SUNNOVO Business Overview
11.19.3 SUNNOVO Innovative Drug CRO (Contract Research Organisation) Introduction
11.19.4 SUNNOVO Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.19.5 SUNNOVO Recent Development
11.20 Pharmaron Beijing
11.20.1 Pharmaron Beijing Company Details
11.20.2 Pharmaron Beijing Business Overview
11.20.3 Pharmaron Beijing Innovative Drug CRO (Contract Research Organisation) Introduction
11.20.4 Pharmaron Beijing Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.20.5 Pharmaron Beijing Recent Development
11.21 Hangzhou Tigermed Consulting
11.21.1 Hangzhou Tigermed Consulting Company Details
11.21.2 Hangzhou Tigermed Consulting Business Overview
11.21.3 Hangzhou Tigermed Consulting Innovative Drug CRO (Contract Research Organisation) Introduction
11.21.4 Hangzhou Tigermed Consulting Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
11.21.5 Hangzhou Tigermed Consulting Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Clinical CRO
 Table 3. Key Players of Preclinical CRO
 Table 4. Global Innovative Drug CRO (Contract Research Organisation) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Region (2020-2025)
 Table 8. Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Region (2026-2031)
 Table 10. Innovative Drug CRO (Contract Research Organisation) Market Trends
 Table 11. Innovative Drug CRO (Contract Research Organisation) Market Drivers
 Table 12. Innovative Drug CRO (Contract Research Organisation) Market Challenges
 Table 13. Innovative Drug CRO (Contract Research Organisation) Market Restraints
 Table 14. Global Innovative Drug CRO (Contract Research Organisation) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Players (2020-2025)
 Table 16. Global Top Innovative Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug CRO (Contract Research Organisation) as of 2024)
 Table 17. Ranking of Global Top Innovative Drug CRO (Contract Research Organisation) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Innovative Drug CRO (Contract Research Organisation) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Innovative Drug CRO (Contract Research Organisation), Headquarters and Area Served
 Table 20. Global Key Players of Innovative Drug CRO (Contract Research Organisation), Product and Application
 Table 21. Global Key Players of Innovative Drug CRO (Contract Research Organisation), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2020-2025)
 Table 25. Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2026-2031)
 Table 27. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2020-2025)
 Table 29. Global Innovative Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Innovative Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2026-2031)
 Table 31. North America Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Charles River Company Details
 Table 47. Charles River Business Overview
 Table 48. Charles River Innovative Drug CRO (Contract Research Organisation) Product
 Table 49. Charles River Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 50. Charles River Recent Development
 Table 51. Labcorp Company Details
 Table 52. Labcorp Business Overview
 Table 53. Labcorp Innovative Drug CRO (Contract Research Organisation) Product
 Table 54. Labcorp Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 55. Labcorp Recent Development
 Table 56. Eurofins Scientific Company Details
 Table 57. Eurofins Scientific Business Overview
 Table 58. Eurofins Scientific Innovative Drug CRO (Contract Research Organisation) Product
 Table 59. Eurofins Scientific Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 60. Eurofins Scientific Recent Development
 Table 61. PPD Company Details
 Table 62. PPD Business Overview
 Table 63. PPD Innovative Drug CRO (Contract Research Organisation) Product
 Table 64. PPD Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 65. PPD Recent Development
 Table 66. ICON Plc Company Details
 Table 67. ICON Plc Business Overview
 Table 68. ICON Plc Innovative Drug CRO (Contract Research Organisation) Product
 Table 69. ICON Plc Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 70. ICON Plc Recent Development
 Table 71. Pharmaron Company Details
 Table 72. Pharmaron Business Overview
 Table 73. Pharmaron Innovative Drug CRO (Contract Research Organisation) Product
 Table 74. Pharmaron Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 75. Pharmaron Recent Development
 Table 76. Inotiv Company Details
 Table 77. Inotiv Business Overview
 Table 78. Inotiv Innovative Drug CRO (Contract Research Organisation) Product
 Table 79. Inotiv Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 80. Inotiv Recent Development
 Table 81. ChemPartner Company Details
 Table 82. ChemPartner Business Overview
 Table 83. ChemPartner Innovative Drug CRO (Contract Research Organisation) Product
 Table 84. ChemPartner Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 85. ChemPartner Recent Development
 Table 86. JOINN Lab Company Details
 Table 87. JOINN Lab Business Overview
 Table 88. JOINN Lab Innovative Drug CRO (Contract Research Organisation) Product
 Table 89. JOINN Lab Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 90. JOINN Lab Recent Development
 Table 91. EVOTEC Company Details
 Table 92. EVOTEC Business Overview
 Table 93. EVOTEC Innovative Drug CRO (Contract Research Organisation) Product
 Table 94. EVOTEC Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 95. EVOTEC Recent Development
 Table 96. Medicilon Company Details
 Table 97. Medicilon Business Overview
 Table 98. Medicilon Innovative Drug CRO (Contract Research Organisation) Product
 Table 99. Medicilon Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 100. Medicilon Recent Development
 Table 101. Crown Bioscience Company Details
 Table 102. Crown Bioscience Business Overview
 Table 103. Crown Bioscience Innovative Drug CRO (Contract Research Organisation) Product
 Table 104. Crown Bioscience Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 105. Crown Bioscience Recent Development
 Table 106. Champion Oncology Company Details
 Table 107. Champion Oncology Business Overview
 Table 108. Champion Oncology Innovative Drug CRO (Contract Research Organisation) Product
 Table 109. Champion Oncology Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 110. Champion Oncology Recent Development
 Table 111. IQVIA Company Details
 Table 112. IQVIA Business Overview
 Table 113. IQVIA Innovative Drug CRO (Contract Research Organisation) Product
 Table 114. IQVIA Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 115. IQVIA Recent Development
 Table 116. Parexel Company Details
 Table 117. Parexel Business Overview
 Table 118. Parexel Innovative Drug CRO (Contract Research Organisation) Product
 Table 119. Parexel Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 120. Parexel Recent Development
 Table 121. Syneos Health Company Details
 Table 122. Syneos Health Business Overview
 Table 123. Syneos Health Innovative Drug CRO (Contract Research Organisation) Product
 Table 124. Syneos Health Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 125. Syneos Health Recent Development
 Table 126. MedPace Company Details
 Table 127. MedPace Business Overview
 Table 128. MedPace Innovative Drug CRO (Contract Research Organisation) Product
 Table 129. MedPace Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 130. MedPace Recent Development
 Table 131. Wuxi AppTec Company Details
 Table 132. Wuxi AppTec Business Overview
 Table 133. Wuxi AppTec Innovative Drug CRO (Contract Research Organisation) Product
 Table 134. Wuxi AppTec Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 135. Wuxi AppTec Recent Development
 Table 136. SUNNOVO Company Details
 Table 137. SUNNOVO Business Overview
 Table 138. SUNNOVO Innovative Drug CRO (Contract Research Organisation) Product
 Table 139. SUNNOVO Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 140. SUNNOVO Recent Development
 Table 141. Pharmaron Beijing Company Details
 Table 142. Pharmaron Beijing Business Overview
 Table 143. Pharmaron Beijing Innovative Drug CRO (Contract Research Organisation) Product
 Table 144. Pharmaron Beijing Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 145. Pharmaron Beijing Recent Development
 Table 146. Hangzhou Tigermed Consulting Company Details
 Table 147. Hangzhou Tigermed Consulting Business Overview
 Table 148. Hangzhou Tigermed Consulting Innovative Drug CRO (Contract Research Organisation) Product
 Table 149. Hangzhou Tigermed Consulting Revenue in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
 Table 150. Hangzhou Tigermed Consulting Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. Innovative Drug CRO (Contract Research Organisation) Picture
 Figure 2. Global Innovative Drug CRO (Contract Research Organisation) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Type: 2024 VS 2031
 Figure 4. Clinical CRO Features
 Figure 5. Preclinical CRO Features
 Figure 6. Global Innovative Drug CRO (Contract Research Organisation) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical Companies Case Studies
 Figure 9. MAH Customer Case Studies
 Figure 10. Others Case Studies
 Figure 11. Innovative Drug CRO (Contract Research Organisation) Report Years Considered
 Figure 12. Global Innovative Drug CRO (Contract Research Organisation) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Innovative Drug CRO (Contract Research Organisation) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Region: 2024 VS 2031
 Figure 15. Global Innovative Drug CRO (Contract Research Organisation) Market Share by Players in 2024
 Figure 16. Global Top Innovative Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug CRO (Contract Research Organisation) as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Innovative Drug CRO (Contract Research Organisation) Revenue in 2024
 Figure 18. North America Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Innovative Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
 Figure 20. United States Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Innovative Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
 Figure 24. Germany Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Innovative Drug CRO (Contract Research Organisation) Market Share by Region (2020-2031)
 Figure 32. China Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Innovative Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
 Figure 40. Mexico Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Innovative Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
 Figure 44. Turkey Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Innovative Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Charles River Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 48. Labcorp Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 49. Eurofins Scientific Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 50. PPD Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 51. ICON Plc Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 52. Pharmaron Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 53. Inotiv Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 54. ChemPartner Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 55. JOINN Lab Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 56. EVOTEC Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 57. Medicilon Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 58. Crown Bioscience Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 59. Champion Oncology Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 60. IQVIA Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 61. Parexel Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 62. Syneos Health Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 63. MedPace Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 64. Wuxi AppTec Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 65. SUNNOVO Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 66. Pharmaron Beijing Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 67. Hangzhou Tigermed Consulting Revenue Growth Rate in Innovative Drug CRO (Contract Research Organisation) Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS